Zimmer Biomet Holdings, Inc. (ZBH) stock analysis
ZBH · Zimmer Biomet Holdings, Inc.
Latest recorded price: USD 101.41
Model-estimated fair value: USD 115.44. This assumption-based estimate is for general research and is not investment advice.
Sector and industry: Healthcare · Medical Devices
At $101.41, ZBH trades 12.2% below the model's base-case value of $115.44. Using Operating FCFF DCF (revenue x margin - reinvestment), the model estimates $84.19 in the conservative case and $150.31 in the optimistic case, with a valuation confidence score of 75/100. About 78% of the value comes from the terminal value, so the result is sensitive to long-term growth and discount-rate assumptions. Fiscal 2025 figures: revenue growth 5.9%, free cash flow margin 17.9%, ROIC 4.4%. The model does not flag any risk signals for this company.